– April 1, 2014
April 1, 2014
View Issues
-
Primary Tumor Resection in Patients Presenting with Metastatic Colorectal Cancer
In a well-controlled retrospective analysis of patients who presented with metastatic colorectal cancer, primary tumor resection was associated with improved overall survival. -
Contralateral Mastectomy Improves 20-year Survival for BRCA-positive Breast Cancer Patients
For patients with BRCA-associated breast cancer, it had been previously demonstrated that a second breast cancer occurs in approximately one-third of patients by 15 years after diagnosis, and that this risk was reduced significantly by contralateral mastectomy. -
Addition of Bevacizumab for Newly Diagnosed Glioblastoma
In a multicenter, randomized, double-blind, placebo-controlled clinical trial of bevacizumab added to standard temozolomide and radiation therapy for patients with glioblastoma multiforme, progression-free survival but not overall survival was enhanced. -
Adding to Survival ... Again: Cervical Cancer
Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity.